FIELD: organic chemistry, pharmacy. SUBSTANCE: invention describes novel compounds of the formula (I) where R1 means -alkyl, halogen-(-alkyl), -alkynyl, hydroxy-(-alkynyl), phenyl, naphthyl, heteroaryl taken among the group including thienyl, pyridyl, thiazolyl, benzothiazolyl; R2 means H or -alkyl; R3 means naphthyl or phenyl possibly substituted with one or two -alkyls, halogen atom, -alkoxyl, hydroxyl, heteroaryl taken among the group including thienyl, 2,3-dihydro- -benzofuranyl; X is oxygen atom and Y means the direct bond, or , or their pharmaceutically acceptable salts. These compounds are antagonists of muscarinic receptors and can be used in treatment of patients with irritable bowel syndrome and enuresis. Also, these compounds can be used as recognition enhancers. EFFECT: improved method of synthesis, valuable pharmacological properties. 18 cl, 27 ex
Title |
Year |
Author |
Number |
QUINOXALINE DERIVATIVES, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION |
1995 |
- Majkl Dzhonatan Frej
- Charl'Z Ehrik Moubrej
- Alan Stoubi
|
RU2135484C1 |
METHOD OF PREPARING (S)-ENANTIOMERS |
1994 |
|
RU2114103C1 |
3-AZETHIDINYLALKYLPIPERIDINES OR PYRROLIDINES AS TACHYKININE ANTAGONISTS, METHODS OF THEIR SYNTHESIS, INTERMEDIATE COMPOUNDS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF TREATMENT |
1996 |
- Aleksandr Roderik Makkenzi
- Allan Patrik Marchington
- Donal'D Stjuart Middleton
- Sandra Dora Medous
|
RU2158264C2 |
DERIVATIVES OF TRIAZOLE, METHODS OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT AND PROPHYLAXIS OF FUNGAL INFECTIONS, INTERMEDIATE COMPOUND |
1997 |
- Mertiashou Charlz V.
- Grin Stjuart
- Stefenson Piter T.
|
RU2176244C2 |
METHOD OF SYNTHESIS OF TRIAZOLES, ULTIMATE AND INTERMEDIATE COMPOUNDS OF METHOD |
1996 |
- Majkl Batters
- Dzhuli Ehnn Kharrison
- Alan Dzhon Pettman
|
RU2156760C2 |
DERIVATIVES OF (AZETHIDINE-1-YLALKYL)-LACTAMES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF TREATMENT OF HUMANS WHEN PATIENTS ARE TREATED BY PRODUCING ANTAGONISTIC EFFECT ON TACHYKININ ACTING IN HUMAN NK-, NK- AND NK-RECEPTORS OR IN THEIR COMBINATION |
1995 |
- Makenzi Aleksandr Roderik
- Marchington Alan Patrik
- Middlton Donal'D Stjuart
- Midouz Sandra Dora
|
RU2150468C1 |
BENZOPYRANES, INTERMEDIATE COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT |
1994 |
- Aleksandr Roderik Makkenzi
- Sandra Marina Monagan
|
RU2122000C1 |
CRYSTALLINE POLYMORPHOUS FORM OF (S,S,S)-(N-(1-[2-CARBOXY-3- -N-MESYLLYSYLAMINO)PROPYL]-1-CYCLOPENTYLCARBONYL)TYROSINE, METHODS OF ITS SYNTHESIS, INTERMEDIATE COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHOD OF PATIENT TREATMENT |
1994 |
- Piter Dzhejms Dann
- Majkl Lesli Kh'Juz
|
RU2131869C1 |
(R)-(METHYLAMINOSULFONYLMETHYL)-3-(N-METHYLPYRROLIDINE-2-YL- -METHYL)-1H-INDOLE FUMARATE, METHOD OF ITS PREPARING, AGENT FOR TREATMENT OF MIRGAINE, PHARMACEUTICAL COMPOSITION FOR MIGRAINE TREATMENT |
1996 |
|
RU2161618C2 |
METHOD OF SYNTHESIS OF DIOXOAZABICYCLOHEXANES |
1996 |
- Stiven Dzhejms Rehj
- Dzhon Artur Rampas
|
RU2156238C2 |